Research library
Weight Management
-
AOD-9604: What the Trials Actually Found, Mechanism, Risks & Legal Status (2026)
An evidence-graded overview of AOD-9604: the six company-run trials and what they measured, how it acts on fat cells, the documented risks,…
-
Tirzepatide vs Retatrutide: Mechanism, Evidence & Key Differences
One molecule carries an FDA label and a boxed warning; the other has published phase 2 data and four phase 3 trials…
-
Semaglutide vs Tirzepatide: Mechanism, Evidence & Key Differences
What the one direct head-to-head trial found, where the two molecules differ mechanistically, and how their evidence bases compare axis by axis.
-
Retatrutide: Research, Mechanism, Risks & Legal Status (2026)
An evidence-graded overview of retatrutide: triple GIP/GLP-1/glucagon receptor pharmacology, what the phase 2 trials found, documented risks, and why it is not…
-
Tirzepatide: Research, Mechanism, Risks & Legal Status (2026)
An evidence-graded overview of tirzepatide: dual GIP/GLP-1 receptor pharmacology, what the SURPASS and SURMOUNT trials found, documented risks, and its 2026 regulatory…
-
Semaglutide: Research, Mechanism, Risks & Legal Status (2026)
An evidence-graded reference on semaglutide: structure, GLP-1 receptor mechanism, the human RCT programmes, labelled risks, and the 2026 US regulatory and compounding…
-
GLP-1 and Incretin Peptides Explained: Semaglutide, Tirzepatide, Retatrutide & More
A hub guide to the incretin class: how GLP-1, GIP and glucagon receptor agonists work, which are approved, what the trials found,…